Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Patient Reported Outcome Measures × 30 days × Clear all

Sponsor

Conditions

Preleukemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pathologic Complete Response 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myelodysplastic Syndromes 1 Lymphoproliferative Disorders 1 Lymphoma 1 Lymphatic Diseases 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Leukemia, B-Cell 1 Leukemia 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hematologic Diseases 1 Breast Neoplasms 1 Bone Marrow Diseases 1

Interventions

pembrolizumab 76 Carboplatin 65 Pemetrexed 56 Cisplatin 41 Paclitaxel 37 Specimen Handling 24 durvalumab 23 Nivolumab 21 Magnetic Resonance Spectroscopy 19 Gemcitabine 18 Docetaxel 15 osimertinib 14 Bevacizumab 13 130-nm albumin-bound paclitaxel 13 atezolizumab 11 cemiplimab 10 Cetuximab 10 Taxes 9 Radiotherapy 9 Immunoglobulin G 9 Drug Therapy 9 Radiosurgery 8 Fluorouracil 8 Disulfides 8 Biopsy 8 tislelizumab 7 amivantamab 7 Observation 7 Ipilimumab 7 Oxaliplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡